Non-operative Management of Lung Cancer Flashcards
Percentage of non-small cell carcinomas operable
25%
Therapeutic options for lung cancer
Radiotherapy Surgery Chemotherapy Immunotherapy Targeted therapies
Essential info to determine optimal therapy
Pathology, stage and performance status
Adjuvant therapy
Therapy given postoperatively
Adjuvant therapy options in non-small cell carcinoma
Chemotherapy
Radiotherapy
Neoadjuvant therapy
Therapy given before operating
Stage III non-small cell carcinoma treatment
Induction chemotherapy followed by radical radiotherapy
Stereotactic ablative therapy
Targeting radiotherapy directly at tumour
Used on tumours up to 4cm and >2cm from airways
Stage IV non-small cell carcinoma treatment
Radiotherapy to primary tumour
Chemotherapy
Average chemotherapy cycles in the UK
4
Immunotherapy is used for
Metastatic disease
Presenting symptom of non-small cell carcinoma bone pain from metastases
Pathological fracture
Treatment for non-small cell carcinoma bone pain from metastases
Palliative radiotherapy
Non-small cell lung cancer non-operative management
Adjuvant therapy Neoadjuvant therapy Immunotherapy Radical radiotherapy Chemotherapy & radiotherapy SABR Targeted drugs
Adjuvant immunotherapy option in non-small cell carcinoma
Durvalumab after chemo and RT